Literature DB >> 19706582

Hospitalization subsequent to diagnosis in young patients with diabetes in Chicago, Illinois.

Carmela L Estrada1, Kirstie K Danielson, Melinda L Drum, Rebecca B Lipton.   

Abstract

OBJECTIVES: Rehospitalization after a diabetes diagnosis in youth signals the failure of outpatient management. We examined risk factors for rehospitalization among young patients with diabetes. PATIENTS AND METHODS: We queried 535 participants diagnosed before 18 years of age from the Chicago Childhood Diabetes Registry. Demographic, social, and clinical data were used in logistic models of diabetes-related rehospitalization, as well as, among those rehospitalized, frequent (> or = once per 2 years' duration) versus infrequent rehospitalization rates.
RESULTS: Mean (range) duration was 5.1 years (0.1-19.2 years). The sample was 55% non-Hispanic black, 11% non-Hispanic white, 26% Hispanic, and 7% other/mixed race; 86% had presumed type 1 diabetes; and 47% were underinsured. Overall, 46% reported rehospitalization for diabetes. In multivariable logistic regression, ever being rehospitalized was significantly associated with diabetes duration (per year, odds ratio [OR]: 1.26; P < .01), female gender (OR: 1.67; P = .01), underinsurance (versus private insurance; OR: 1.79; P < .01), presumed phenotype (non-type 1 diabetes versus type 1; OR: 0.32; P < .01), and diagnosis at a community hospital (versus tertiary care facility; OR: 1.96; P < .01) and tended to be higher for those of nonwhite race (OR: 1.94; P = .07). Among those rehospitalized, multivariable associations with frequent rehospitalization were presumed phenotype (non-type 1 diabetes versus type 1; OR: 2.74; P = .04), head of household not working (versus employed; OR: 1.88; P = .02), and younger age at questionnaire (per year; OR: 0.94; P = .01).
CONCLUSIONS: Rehospitalization is common in young patients with diabetes, especially for those with limited resources, indicating the need for improved outpatient services. Comprehensive initial education and support available to young patients with diabetes diagnosed at tertiary care facilities and their families may have lasting protective effects.

Entities:  

Mesh:

Year:  2009        PMID: 19706582      PMCID: PMC2888679          DOI: 10.1542/peds.2008-3826

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

1.  The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.

Authors:  Angela D Liese; Ralph B D'Agostino; Richard F Hamman; Patrick D Kilgo; Jean M Lawrence; Lenna L Liu; Beth Loots; Barbara Linder; Santica Marcovina; Beatriz Rodriguez; Debra Standiford; Desmond E Williams
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

2.  Increased rates of morbidity, mortality, and charges for hospitalized children with public or no health insurance as compared with children with private insurance in Colorado and the United States.

Authors:  James Todd; Carl Armon; Anne Griggs; Steven Poole; Stephen Berman
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

3.  Hospitalization among diabetic children and adolescents and non-diabetic control subjects: a prospective population-based study.

Authors:  A Icks; J Rosenbauer; B Haastert; G Giani
Journal:  Diabetologia       Date:  2001-10       Impact factor: 10.122

4.  The impact of psychiatric comorbidities on readmissions for diabetes in youth.

Authors:  Michelle M Garrison; Wayne J Katon; Laura P Richardson
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

5.  Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes.

Authors:  Britta M Svoren; Lisa K Volkening; Deborah A Butler; Elaine C Moreland; Barbara J Anderson; Lori M B Laffel
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

6.  Predictors of acute complications in children with type 1 diabetes.

Authors:  Arleta Rewers; H Peter Chase; Todd Mackenzie; Philip Walravens; Mark Roback; Marian Rewers; Richard F Hamman; Georgeanna Klingensmith
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

7.  Self-reported social class, self-management behaviors, and the effect of diabetes mellitus in urban, minority young people and their families.

Authors:  Rebecca Lipton; Melinda Drum; Deborah Burnet; Maureen Mencarini; Andrew Cooper; Barry Rich
Journal:  Arch Pediatr Adolesc Med       Date:  2003-09

8.  Re-hospitalization after diagnosis of diabetes varies by gender and socioeconomic status in urban African-American and Latino young people.

Authors:  Rebecca B Lipton; Kristina M Zierold; Melinda L Drum; Marisa Klein-Gitelman; Arthur F Kohrman
Journal:  Pediatr Diabetes       Date:  2002-03       Impact factor: 4.866

Review 9.  Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

10.  Adherence to guidelines for and disparities in diabetes care utilization in Medicaid children.

Authors:  Kazim Sheikh; Claudia M Bullock; Yanming Jiang; Stephen D Ketner
Journal:  J Pediatr Endocrinol Metab       Date:  2008-04       Impact factor: 1.634

View more
  9 in total

1.  Onset features and subsequent clinical evolution of childhood diabetes over several years.

Authors:  Rebecca B Lipton; Melinda L Drum; Kirstie K Danielson; Siri Aw Greeley; Graeme I Bell; William A Hagopian
Journal:  Pediatr Diabetes       Date:  2011-03-23       Impact factor: 4.866

2.  HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes.

Authors:  Rebecca B Lipton; Melinda Drum; Siri Atma W Greeley; Kirstie K Danielson; Graeme I Bell; William A Hagopian
Journal:  Pediatr Diabetes       Date:  2011-03-21       Impact factor: 4.866

3.  Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Authors:  Ashley Pinckney; Mark R Rigby; Lynette Keyes-Elstein; Carol L Soppe; Gerald T Nepom; Mario R Ehlers
Journal:  Clin Ther       Date:  2016-05-18       Impact factor: 3.393

Review 4.  Psychosocial aspects of type 1 diabetes in Latino- and Asian-American youth.

Authors:  Kajal K Gandhi; Tom Baranowski; Barbara J Anderson; Nidhi Bansal; Maria J Redondo
Journal:  Pediatr Res       Date:  2016-04-13       Impact factor: 3.756

5.  Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.

Authors:  Wojciech Fendler; Anna Iza Baranowska; Beata Mianowska; Agnieszka Szadkowska; Wojciech Mlynarski
Journal:  Acta Diabetol       Date:  2011-10-01       Impact factor: 4.280

6.  Evidence for a persistent, major excess in all cause admissions to hospital in children with type-1 diabetes: results from a large Welsh national matched community cohort study.

Authors:  Adrian Sayers; Daniel Thayer; John N Harvey; Stephen Luzio; Mark D Atkinson; Robert French; Justin T Warner; Colin M Dayan; Susan F Wong; John W Gregory
Journal:  BMJ Open       Date:  2015-04-13       Impact factor: 2.692

7.  Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4).

Authors:  E A J M Spaans; P R van Dijk; K H Groenier; P L P Brand; N Kleefstra; H J G Bilo
Journal:  BMC Endocr Disord       Date:  2018-08-17       Impact factor: 2.763

8.  Temporal patterns of hospitalizations for diabetic ketoacidosis in children and adolescents.

Authors:  Arpita Kalla Vyas; Lavi Oud
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

9.  Patterns of engagement with the health care system and risk of subsequent hospitalization amongst patients with diabetes.

Authors:  Paul E Ronksley; Pietro Ravani; Claudia Sanmartin; Hude Quan; Braden Manns; Marcello Tonelli; Brenda R Hemmelgarn
Journal:  BMC Health Serv Res       Date:  2013-10-09       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.